Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why YS Biopharma Stock Is Rocketing Higher

YS Biopharma Co., Ltd. (NASDAQ: YS) shares are rocketing higher Friday after the company announced the purchase of shares by company officers.
byErica Kollmann
August 25, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

YS Biopharma Co., Ltd. (NASDAQ:YS) shares are rocketing higher Friday after the company announced the purchase of shares by company officers.

The Details:

YS Biopharma announced that chairperson, Mr. Yi Zhang, and its CEO, Dr. Hui Shao, have purchased 429,188 of the company’s ordinary shares at an average price of $1.407 per share, and 46,300 ordinary shares at an average price of $1.46 per share on the open market.

YS shares are moving higher on very heavy trading volume. According to data from Benzinga Pro, more than 35.2 million shares have been traded in the session, far exceeding the stock’s 100-day average of just over 651 thousand shares.

YS Biopharma is currently one of the top trending tickers on Yahoo! Finance

Related News: What’s Going On With Ideanomics Stock Today?

YS Price Action: According to Benzinga Pro, YS Biopharma shares are up 50% at $1.17 at the time of publication.

Image: TheDigitalArtist from Pixabay

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Tesla Eyes Chinese Data Center To Boost Autonomous Driving Tech: Report

By Shivani Kumaresan
May 17, 6:59 AM
Tesla, led by Elon Musk, is reportedly eyes a data center in China to enhance its self-driving technology. This move aligns with their strategy to locally process data for the Full Self-Driving (FSD) system, reflecting a shift to secure local processing capabilities and adapt to the competitive EV market. The initiative underscores Tesla's focus on leveraging Chinese data for AI development amid U.S. tech transfer restrictions.

BIDU